Abstract
Consistent evidence supporting the use of cannabinoids for management of acute pain is lacking. A small number of observational studies suggest cannabinoid use is associated with reduced opioid use but pain scores remain unchanged. The majority of randomized trials involving a variety of cannabinoid compounds have shown no benefit for acute pain. Chronic cannabis users may be at increased risk of experiencing elevated levels of acute pain and these individuals may require greater quantities of opioids compared to non-cannabis users. There is also evidence suggesting that chronic, high-dose cannabis users may be at increased risk of perioperative cardiovascular complications.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
